Filing Flows

Filing Flows › West Pharmaceutical Services (WST) › Next earnings date

West Pharmaceutical Services (WST) earnings: beat the estimate

West Pharmaceutical Services (WST) reported on Oct 29, 2026 and beat the EPS estimate: $2.66 against $2.20 (+21.1%). Revenue was $874M for Q3 2026, +9% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+21.1% vs estimate
Beat rate100%

The last report

West Pharmaceutical Services reported revenue of $874M for the third quarter 2026 (+9% Y/Y), net earnings $214M: Proprietary Products $729M, West Vantage $146M. How it makes money → · Every quarter →

West Pharmaceutical Services: EPS against the estimate, last 5 reportsWest Pharmaceutical Services: EPS against the estimate, last 5 reportsEstimateReported$1.71$1.96Oct 25$1.83$2.04Feb 26$1.68$2.13Apr 26$2.08$2.37Jul 26$2.20$2.66Oct 26
Latest (Oct 26): Estimate $2.20, Reported $2.66.
WST: the stock's move on each reportWST: the stock's move on each reportJul 23, 2026-8.4%Apr 23, 2026+11.6%Feb 12, 2026+1.8%Oct 23, 2025+7.4%

West Pharmaceutical Services' latest quarter

West Pharmaceutical Services, Q3 2026: revenue $874M (+9% year over year), operating margin 30.6%, net earnings $214M, operating cash flow $190M. The chart follows the revenue to costs, profit and cash.

Questions

Did West Pharmaceutical Services beat earnings?

West Pharmaceutical Services (WST) reported on Oct 29, 2026 and beat the EPS estimate: $2.66 against $2.20 (+21.1%).

When does WST report earnings?

The next date is not set yet.

Does West Pharmaceutical Services usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.